Chondroitin sulfate functionalized liposomes for solid tumor targeting

Journal of Drug Targeting

Volumn 19, Issue 4, 2011, Pages 251-257

  Bagari, Rashmi ^a   Bansal, Divya ^a   Gulbake, Arvind ^a   Jain, Aviral ^a   Soni, Vandana ^a   Jain, Sanjay K ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

chondroitin sulfate; Liposomes; solid tumors

Indexed keywords

CHONDROITIN SULFATE; ETOPOSIDE; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG RELEASE; DRUG TARGETING; DRUG TISSUE LEVEL; DRUG TUMOR LEVEL; DRUG UPTAKE; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; KIDNEY; LIVER; LUNG; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SOLID TUMOR; SPLEEN; SURFACE PROPERTY; TUMOR MODEL; ZETA POTENTIAL;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CHONDROITIN SULFATES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ETOPOSIDE; FEMALE; HUMANS; LIPOSOMES; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; TISSUE DISTRIBUTION;

EID: 79953004269     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2010.492525     Document Type: Article

References (17)

1. Alving CR. (1991). Liposomes as carriers of antigens and adjuvants. J Immunol Methods, 140, 1-13.
2. Ashley DM, Meier L, Kerby T, Zalduondo FM, Friedman HS, Gajjar A, Kun L, Dufner PK, Smith S, Longee D. (1996). Response of recurrent medulloblastoma to low-dose oral etoposide. J Clin Oncol, 14, 1922-1927. (Pubitemid 26185467)
3. Bangham AD, Standish MM, Watkins JC. (1965). Difusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol, 13, 238-252.
4. Chamberlain MC. (1993). Recurrent brainstem gliomas treated with oral VP-16. J Neurooncol, 15, 133-139. (Pubitemid 23136028)
5. Fry DW, White JC, Goldman ID. (1978). Rapid separation of low molecular weight solutes from liposomes without dilution. Anal Biochem, 90, 809-815. (Pubitemid 9087732)
6. Gregoriadis G. (1990). Immunological adjuvants: a role for liposomes. Immunol Today, 11, 89-97. (Pubitemid 20062716)
7. Gupta Y Jain A, Jain SK. (2007). Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain. J Pharm Pharmacol, 59, 935-940. (Pubitemid 47051073)
8. Hoare DG, Koshland DE. (1966). A procedure for the selective modifcation of carboxyl group in proteins. J Amer Chem Society, 88, 2057-2058.
9. Lee CM, Tanaka T, Murai T, Kondo M, Kimura J, Su W, Kitagawa T, Ito T, Matsuda H, Miyasaka M. (2002). Novel chondroitin sulfate-binding cationic liposomes loaded with cisplatin efciently suppress the local growth and liver metastasis of tumor cells in vivo. Cancer Res, 62, 4282-4288. (Pubitemid 34827283)
10. Leserman L. (2004). Liposomes as protein carriers in immunology. J Liposome Res, 14, 175-189. (Pubitemid 40052469)
11. Maruyama K, Holmberg E, Kennel SJ, Klibanov A, Torchilin VP, Huang L. (1990). Characterization of in vivo immunoliposome targeting to pulmonary endothelium. J Pharm Sci, 79, 978-984. (Pubitemid 20376189)
12. Mishra PK, Gulbake A, Jain A, Vyas SP, Jain SK. (2009). Targeted delivery of an anti-cancer agent via steroid coupled liposomes. Drug Deliv, 16, 437-447.
13. Muggia FM. (1997). Phase II study of liposomal doxuribicin in refractory ovarian cancer: antitumor activity and toxicity modifcation by liposomal encapsulation. J. Clin. Oncol, 15, 987-993. (Pubitemid 27106281)
14. Northfeld DW. (1997). Liposomal anthracycline chemotherapy in the treatment of AIDS-related Kaposi's salcoma. Oncology, 11, 21-31.
15. Sneath RJ, Mangham DC (1986). Te normal structure and function of CD44 and its role in neoplasia. MP, Mol Pathol, 51, 191-200.
16. Sorensen EN, Weisman G, Vidaver GA. (1977). A sephadex column procedure for measuring uptake and loss of low molecular weight solutes from small, lipid-rich vesicles. Anal Biochem, 82, 376-384. (Pubitemid 8194188)
17. Takakura Y, Hashida M. (1986). Macromolecular carrier systems for targeted drug delivery: pharmacokinetic considerations on biodistribution. Pharm Res, 13, 820-831.